CICLOSPORIN

CICLOSPORIN (12663L)

ciclosporin 0.1% eye drops, 30 x 0.3 mL ampoules
12663L
Body System:
Manner of administration:Application To The Eye
General Schedule
Authority Required

Restriction

Indication: Chronic severe dry eye disease with keratitis
Treatment phase: Initial treatment for up to the first 180 days of treatment

Restriction

Indication: Chronic severe dry eye disease with keratitis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $82.16 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Ikervis

CICLOSPORIN (13284E)

ciclosporin 0.09% eye drops, 60 x 0.25 mL ampoules
13284E
Body System:
Manner of administration:Application To The Eye
General Schedule
Authority Required

Restriction

Indication: Chronic severe dry eye disease with keratitis
Treatment phase: Initial treatment for up to the first 180 days of treatment

Restriction

Indication: Chronic severe dry eye disease with keratitis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $82.16 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Cequa

CICLOSPORIN (13883Q)

ciclosporin 25 mg capsule, 30
13883Q
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 120 # of repeats: 3 DPMQ: $106.32 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Ciclosporin
CICLOSPORIN-WGR
Neoral 25

CICLOSPORIN (13910D)

ciclosporin 50 mg capsule, 30
13910D
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 120 # of repeats: 3 DPMQ: $210.28 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Ciclosporin
CICLOSPORIN-WGR
Neoral 50

CICLOSPORIN (13911E)

ciclosporin 100 mg capsule, 30
13911E
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 120 # of repeats: 3 DPMQ: $418.72 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Ciclosporin
CICLOSPORIN-WGR
Neoral 100

CICLOSPORIN (13999T)

ciclosporin 10 mg capsule, 60
13999T
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 240 # of repeats: 3 DPMQ: $172.32 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral 10

CICLOSPORIN (14001X)

ciclosporin 100 mg/mL oral liquid, 50 mL
14001X
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 4 # of repeats: 3 DPMQ: $1,392.72 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral

CICLOSPORIN (5631J)

ciclosporin 50 mg/mL injection, 10 x 1 mL ampoules
5631J
Body System:
Manner of administration:Injection
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 6628)

Indication: Management of transplant rejection
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 10 # of repeats: 0 DPMQ: $54.10 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Sandimmun

CICLOSPORIN (5632K)

ciclosporin 10 mg capsule, 60
5632K
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 6643)

Indication: Management of transplant rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6660)

Indication: Severe atopic dermatitis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 15360)

Indication: Severe psoriasis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6631)

Indication: Nephrotic syndrome
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6638)

Indication: Severe active rheumatoid arthritis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 120 # of repeats: 5 DPMQ: $74.40 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral 10

CICLOSPORIN (5633L)

ciclosporin 100 mg/mL oral liquid, 50 mL
5633L
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 6643)

Indication: Management of transplant rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6660)

Indication: Severe atopic dermatitis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 15360)

Indication: Severe psoriasis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6631)

Indication: Nephrotic syndrome
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6638)

Indication: Severe active rheumatoid arthritis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 4 # of repeats: 5 DPMQ: $1,263.16 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral